10 likes | 28 Views
In 2017, the diagnosed prevalent population of Mydriasis in the United States was 3,580,350. In the United States the Cataract Surgeries performed in the age-specific cases (70u201379) in 2017 were 1,390,000. <br><br>The market size of Mydriasis in the seven major markets was USD 104.52 million in 2017.<br><br>Rising Geriatric population and cost-effectiveness of the Current Standard of Care are the key factors expected to drive the Mydriasis market forward in the coming years. <br><br>The key companies in the Mydriasis market include Ocuphire Pharma, Thu00e9a Laboratories, Omeros Corporation and others. <br><br>For more detailed information on Mydriasis market, visit: <br>https://www.delveinsight.com/report-store/mydriasis-market<br><br><br>
E N D